Wahl P, Drennan P, Schlappi M, Achermann Y, Leunig M, Gautier E
EFORT Open Rev. 2024; 9(12):1106-1119.
PMID: 39620563
PMC: 11619733.
DOI: 10.1530/EOR-24-0022.
Cattrall J, Asin-Prieto E, Freeman J, Troconiz I, Kirby A
Eur J Clin Microbiol Infect Dis. 2019; 38(12):2311-2321.
PMID: 31494827
PMC: 6858297.
DOI: 10.1007/s10096-019-03679-9.
Zozaya H, Gutierrez L, Bernad M, Sumano H
Acta Vet Scand. 2013; 55:21.
PMID: 23497696
PMC: 3608154.
DOI: 10.1186/1751-0147-55-21.
Ismail M
Vet Res Commun. 2007; 31(4):467-76.
PMID: 17216308
DOI: 10.1007/s11259-006-3464-4.
Daly R, Fitzgerald Jr R, Washington 2nd J
Antimicrob Agents Chemother. 1982; 22(3):461-9.
PMID: 7137985
PMC: 183766.
DOI: 10.1128/AAC.22.3.461.
Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizine.
Pfeffer M, GAVER R, Ximenez J
Antimicrob Agents Chemother. 1983; 24(6):915-20.
PMID: 6660858
PMC: 185407.
DOI: 10.1128/AAC.24.6.915.
Effects of cirrhosis on kinetics of aztreonam.
Macleod C, Bartley E, Payne J, Hudes E, Vernam K, Devlin R
Antimicrob Agents Chemother. 1984; 26(4):493-7.
PMID: 6542764
PMC: 179951.
DOI: 10.1128/AAC.26.4.493.
Distribution of [14C]aztreonam in rat tissue.
Singhvi S, Ita C, Shaw J, Migdalof B
Antimicrob Agents Chemother. 1984; 26(2):127-31.
PMID: 6541450
PMC: 284104.
DOI: 10.1128/AAC.26.2.127.
Disposition of [14C]aztreonam in rats, dogs, and monkeys.
Kripalani K, Singhvi S, Weinstein S, Everett D, Bathala M, Dean A
Antimicrob Agents Chemother. 1984; 26(2):119-26.
PMID: 6541449
PMC: 284103.
DOI: 10.1128/AAC.26.2.119.
Moxalactam penetration of normal and osteomyelitic bone.
Fitzgerald Jr R
Arch Orthop Trauma Surg (1978). 1983; 101(4):273-81.
PMID: 6224472
DOI: 10.1007/BF00379943.
Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.
Philipson A, Stiernstedt G, Ehrnebo M
Clin Pharmacokinet. 1987; 12(2):136-44.
PMID: 3829560
DOI: 10.2165/00003088-198712020-00004.
Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants.
Suh B, Wadsworth S, Lichtenwalner D
J Clin Invest. 1987; 80(4):1125-31.
PMID: 3654972
PMC: 442355.
DOI: 10.1172/JCI113169.
High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine.
Barbhaiya R, Forgue S, Shyu W, Papp E, PITTMAN K
Antimicrob Agents Chemother. 1987; 31(1):55-9.
PMID: 3566239
PMC: 174651.
DOI: 10.1128/AAC.31.1.55.
Simple spectrophotometric assay for measuring protein binding of penem antibiotics to human serum.
Gootz T, Subashi T, Lindner D
Antimicrob Agents Chemother. 1988; 32(2):159-63.
PMID: 3364940
PMC: 172127.
DOI: 10.1128/AAC.32.2.159.
In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns.
Wadsworth S, Suh B
Antimicrob Agents Chemother. 1988; 32(10):1571-5.
PMID: 3190184
PMC: 175921.
DOI: 10.1128/AAC.32.10.1571.
Disposition of fosinopril sodium in healthy subjects.
Singhvi S, Duchin K, Morrison R, Willard D, Everett D, FRANTZ M
Br J Clin Pharmacol. 1988; 25(1):9-15.
PMID: 2967089
PMC: 1386608.
DOI: 10.1111/j.1365-2125.1988.tb03275.x.
Microdialysis sampling for determination of plasma protein binding of drugs.
Herrera A, Scott D, Lunte C
Pharm Res. 1990; 7(10):1077-81.
PMID: 2281040
DOI: 10.1023/a:1015955503708.
Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.
Smyth R, Pfeffer M, Glick A, Van Harken D, Hottendorf G
Antimicrob Agents Chemother. 1979; 16(5):615-21.
PMID: 526003
PMC: 352915.
DOI: 10.1128/AAC.16.5.615.